FIELD: medicine.
SUBSTANCE: agent contains chitosan salt 75-95 wt % of polydisperse powders of chitosan hydrochloride, hydrobromide, formate, acetate, succinate, citrate, glycolate or lactate and polyhexamethylene guanidine hydrochloride 4-20 wt %. The chitosan salt and polyhexamethylene guanidine hydrochloride are covalently cross-linked by a polyfunctional compound 1-5 wt % of glycidyl ethers. The chitosan salt is specified with an average particle size of 0.2÷2.0 mm, degree of chitosan deacetylation 0.75÷0.95, and molecular weight 10÷500 kDa. The above polyfunctional compound of glycidyl ethers is presented by a diglycidyl ether of butandiol, di- or triethylene glycol or propylene glycol, oligoethylene oxide, as well as triglycidyl ethers of glycerol or trimethylol propane.
EFFECT: method possesses high blood sorption capacity, rapid hemostasis time and high antimicrobial activity.
3 cl, 2 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
LOCAL HAEMOSTATIC ANTIBACTERIAL AGENT | 2021 |
|
RU2776015C1 |
LOCAL HEMOSTATIC AGENT WITH ENHANCED ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2675631C1 |
LOCAL HEMOSTATIC ANTIBACTERIAL AGENT, METHOD FOR PRODUCTION THEREOF, AND MEDICAL PRODUCT BASED THEREON | 2020 |
|
RU2756316C1 |
LOCAL HEMOSTATIC MEDICATION | 2009 |
|
RU2414225C1 |
LOCAL HEMOSTATIC AGENT | 2012 |
|
RU2522206C1 |
HEMOSTATIC AGENT BASED ON CHITOSAN AEROGEL | 2020 |
|
RU2743425C1 |
COMPOSITION FOR WOUND TREATMENT AND PRODUCTS ON ITS BASIS | 2011 |
|
RU2467767C1 |
FLUID HEMOSTATIC AGENT | 2023 |
|
RU2805923C1 |
HEMOSTATIC AGENT BASED ON CHITOSAN | 2023 |
|
RU2807862C1 |
HAEMOSTATIC AGENT BASED ON CHITOSAN SUCCINATE AND CALENDULA EXTRACT | 2019 |
|
RU2694372C1 |
Authors
Dates
2014-06-10—Published
2013-02-26—Filed